This free live virtual event is now open for public registration 

APRIL 15, 2021

10:00 AM to 1:30 PM (EDT) [3:00 PM to 6:30 PM GMT][4:00 PM to 7:30 PM CEST]

Please register in advance

Everyone is welcome to join for all or part of the sessions.

Registered participants can submit questions in advance.

Hosted by 

President & CEO

World Travel and Tourism Council (WTTC)

President & CEO  

Carnival Corporation & PLC

Once again connecting top global scientists

and health experts with the general public 

The World Travel & Tourism Council (WTTC), the world's largest cruise company Carnival Corporation, U.S. Travel Association, and Hilton are sponsoring a 2021 Global Science Summit on COVID-19 on April 15, 2021.

What we’ve learned since last summer

The Summit will bring together top global scientists and health experts discussing the latest discoveries, evidence-based insights and best practices for living in a world with COVID-19 and will build on a well-received similar forum hosted last year by the WTTC and Carnival Corporation. This year’s event will continue those discussions while helping to build global and industry-wide understanding of COVID-19’s impact on society, including the necessary steps to move forward.

 

The event will be of interest to global tourism leaders including WTTC members, government agencies, destination partners, trade and private businesses who want to hear up-to-the-minute science and medical research that can be used to inform practical, adaptable and science-based solutions for mitigating COVID-19 in order move beyond the pandemic.

 

A series of panels will focus on critical areas of science related to COVID-19 with panelists sharing the latest knowledge of key topic areas, including the epidemiology of the virus, transmission, testing, prevention, treatments, vaccines and the newest approaches to help mitigate and live with

COVID-19.

Event Agenda

10:00 AM to 1:30 PM (EDT) [3:00 PM to 6:30 PM GMT][4:00 PM to 7:30 PM CEST]

Our Panelists

Dr. Michael Diamond, M.D., Ph.D.

Herbert S. Gasser Professor of Medicine at

Washington University 

Dr. Diamond is recognized internationally for his work involving Zika, West Nile, chikungunya, and related emerging viruses.

Dr. Steven Gordon, M.D. 

Chairman, Department of Infectious Disease,

Cleveland Clinic, Respiratory Institute and Professor of Medicine, The Lerner College of Medicine, Case Western University

Dr. Gordon has been focused on hospital infection prevention, including device-associated and opportunistic infections in immunocompromised patients.

Dr. Michael Lin, M.D., Ph.D. 

Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at

Stanford University

A NIH Pioneer Award recipient, Dr. Lin develops protein based tools for molecular imaging and control of gene and viral therapy.

Dr. William Morice, II, M.D., Ph.D.

Chair, Department of Laboratory Medicine and Pathology at Mayo Clinic, President, Mayo Clinic Laboratories, and Professor of Laboratory Medicine and Pathology

Dr. Morice is an expert in diagnostic testing serving in leadership roles for numerous boards and partnerships to enhance understanding of clinical diagnostics and test utilization.

Dr. Jewel Mullen, M.D., M.P.H.

Associate Dean for Health Equity, University of Texas at Austin, Dell Medical School

Dr. Mullen is an internist, epidemiologist and public health physician leader and the former principal deputy assistant secretary for health in the U.S. Department of Health and Human Services (HHS).

Dr. Emil Christian Reisinger

Director of the Department of Tropical Medicine and Infectious Diseases at the Department of Internal Medicine at the University of Rostock, Dean of the University and Member of the Board of the University Hospital Rostock

An infectious and tropical disease expert, Dr. Reisinger is COVID-19 adviser to the government in Mecklenburg-Vorpommern and Germany Coordinating Investigator for the trial of Johnson & Johnson's Janssen COVID-19 vaccine.

Dr. Clare Rock, M.D., M.S.

Associate Professor of Medicine, Associate Hospital Epidemiologist, Johns Hopkins University School of Medicine

Dr. Rock has significant expertise in institutional COVID-19 support, including as Hospital Epidemiology and Infection Control COVID-19 Johns Hopkins Health System Incident Commander. Specific expertise and experience include COVID-19 testing strategies for the workplace, businesses, & community, return to work policies, return to business strategies, outbreak and cluster management, contact tracing, addressing COVID-19 vaccine hesitancy in the workplace and the community.

Dr. Stefano Vella, M.D.

Adjunct Professor of Global Health at the Catholic University of Rome and a member of the Program Committee of Horizon Europe - Health Cluster, the Research Program of the European Commission

Dr. Vella specializes in infectious diseases and internal medicine and is a researcher in pathogenesis and therapy of viral infections. Specific research has been conducted by Dr. Vella on major pandemics, specifically on HIV/AIDS and Tuberculosis.